Silence Therapeutics plc (SLN) — Dilution Risk Analysis
Current Snapshot
Silence Therapeutics plc (SLN) has a DilutionWatch score of 61/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 61/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 8, 8-K/A 1, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-02-13 | 0001104659-26-014603 |
| 4 | 2026-01-06 | 0001717972-26-000003 |
| 4 | 2026-01-06 | 0001766456-26-000002 |
| 4 | 2026-01-06 | 0001639860-26-000002 |
| 4 | 2026-01-06 | 0001226020-26-000002 |
| 4 | 2026-01-06 | 0002048873-26-000002 |
| 8-K/A | 2025-12-22 | 0001193125-25-328684 |
| 3 | 2025-12-22 | 0002048873-25-000004 |
| 4 | 2025-12-22 | 0002048873-25-000005 |
| 4 | 2025-12-22 | 0001307218-25-000003 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 13 months | Source |
| Three-year share count growth | 19.26% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 61/10) Source
- Cash Runway
- 13 months Source
- Share Count Growth (3-Year)
- 19.26% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.